CAS: 396091-77-3: Pasireotide L-aspartate ntsev

Xa kev nug
CAS: 396091-77-3: Pasireotide L-aspartate ntsev
Paub meej
CAS: 396091-77-3 Nr
Cov qauv tseem ceeb: Hexapeptide broad -spectrum somatostatin analog. Ib khub ntawm intramolecular disulfide daim ntawv cog lus tsim ib qho kev ruaj khov cyclic active conformation, hloov nrog ntau D-amino acids. Nws khi rau plaub receptor subtypes SSTR1/2/3/5 nrog siab affinity thiab potently inhibits secretion ntawm ntau yam tshuaj hormones. L- aspartate ntsev daim ntawv ua tau zoo txhim kho dej solubility thiab formulation tolerability.
Peb kuj muab cov lus qhia tshwj xeeb los ntawm crude mus rau 99% purity, thov hu rau peb kom paub meej!
** Cov ntaub ntawv ntsig txog **
COA/MS/HPLC Report
Peptide Dissolution thiab Cia Phau Ntawv Qhia
Kev faib tawm yam khoom
Pharmaceutical Peptides
Share to
Hauj lwm lawm

Shanghai Sonyt Biotechnology Co., Ltd. yog ib qho ntawm cov ua lag luam thiab cov chaw muag khoom ntawm cas: 396091-77-3: pasireotide l-aspartate ntsev hauv Suav teb, kuj txhawb kev pabcuam kev cai. Txais tos rau cov lag luam wholesale bulk zoo cas: 396091-77-3: pasireotide l-aspartate ntsev los ntawm peb lub hoobkas. Tiv tauj peb kom paub meej ntxiv.

 

Khoom npe CAS: 396091-77-3: Pasireotide L-aspartate ntsev
Kev piav qhia Pasireotide yog ib qho tshiab - tiam dav - spectrum somatostatin analog. Nws khi rau plaub tus somatostatin receptor subtypes SSTR1, SSTR2, SSTR3 thiab SSTR5 nrog kev sib raug zoo siab, ntawm cov uas muaj kev sib raug zoo rau SSTR5 yog qhov siab dua li ib txwm octreotide. Nws tuaj yeem cuam tshuam qhov tso tawm ntawm ntau yam tshuaj hormones endocrine nrog rau kev loj hlob hormone, adrenocorticotropic hormone, glucagon thiab insulin. Nws cov qauv cyclic thiab D-amino acid hloov kho tau zoo heev txhim kho peptidase tsis kam thiab hauv vivo ib nrab- lub neej. Nws qhia meej cov tshuaj hormones-inhibiting thiab tiv thaiv- cov qog nqaij hlav loj hlob hauv cov qauv ntawm Cushing's kab mob, acromegaly thiab neuroendocrine hlav. Nws yog cov cuab yeej tseem ceeb peptide rau kev tshawb nrhiav kab mob endocrine mechanism, neuroendocrine oncology thiab peptide tshuaj txhim kho.
Peptide Purity (HPLC, %) 95% / 98% / 99%
Dawb puag molecular mis C₅₈H₆₆N₁₂O₉S₂
Dawb puag molecular hnyav (Da) 1047.35, siab dua rau L-aspartate form
Hom qauv Cyclic hexapeptide, ib khub ntawm intramolecular disulfide bonds, muaj D-amino acids, L-aspartate ntsev

 

Product Basic Information Table

 

Khoom Lub Npe Lus Askiv Product Abbreviation / Alias Function Tags (comma-sib cais) Core Structure Molecular Formula Exact Mass (Da) Qhov nruab nrab MW (Da) Daim ntawv ntsev Ntev (aa)
Pasireotide L-aspartate ntsev Pasireotide L-aspartate Broad -spectrum somatostatin receptor agonist, ntau-hormone suppression, Cushing's disease/acromegaly research, neuroendocrine oncology Hexapeptide broad-spectrum somatostatin analog nrog ib qho intramolecular disulfide daim ntawv cog lus tsim kom muaj kev ruaj khov cyclic conformation, hloov nrog ntau D-amino acids; siab affinity rau SSTR1 / 2 / 3 / 5, nrog ntau dua SSTR5 affinity dua li ib txwm analogs Dawb peptide: C₅₈H₆₆N₁₂O₉S₂ 1046.45 1047.35 L-aspartate 6

Physicochemical Solubility & Cia Parameters

 

Khoom Code Qhov tshwm sim Ntev - Lub Sij Hawm Cia Luv - Lub Sij Hawm Cia Kev daws teeb meem Khoom hmoov ruaj khov
PEB-PAS001 hmoov dawb Khaws ntawm -20 degree, kaw, qhuav thiab tiv thaiv los ntawm lub teeb. Aliquot rau cia. nruj me ntsis kom tsis txhob muaj zog txo cov neeg sawv cev los tiv thaiv disulfide daim ntawv cog lus cleavage. ruaj khov rau 1 lub hlis ntawm 2-8℃nyob rau hauv kaw qhuav; nkoj ntawm cov pob khov nab kuab pom zoo. Nyob ruaj khov rau 14 hnub ntawm 4 degree. L- aspartate ntsev daim ntawv muaj cov dej solubility zoo dua li peptide dawb; solubility yog ntxiv txhim kho nyob rau hauv dilute acid. Disulfide daim ntawv cog lus tau nrawm nrawm thiab tsis ua haujlwm los ntawm cov neeg ua haujlwm txo qis. ruaj khov rau 3 xyoos ntawm -20 degree, qhuav thiab tiv thaiv los ntawm lub teeb.

Functional Description

 

Khoom Code Frontend Short Summary (rau cov npe tshawb nrhiav) Cov lus piav qhia txog kev ua haujlwm lom neeg lom neeg Cov cheeb tsam tshawb fawb (comma- cais) Lub Hom Phiaj / Txoj Kev
PEB-PAS001 Broad -spectrum multi-subtype somatostatin analog potently inhibits ntau yam endocrine hormones Pasireotide yog ib qho tshiab - tiam dav - spectrum somatostatin analog. Nws khi rau plaub tus somatostatin receptor subtypes SSTR1, SSTR2, SSTR3 thiab SSTR5 nrog kev sib raug zoo siab, ntawm cov uas muaj kev sib raug zoo rau SSTR5 yog qhov siab dua li ib txwm octreotide. Nws tuaj yeem cuam tshuam qhov tso tawm ntawm ntau yam tshuaj hormones endocrine nrog rau kev loj hlob hormone, adrenocorticotropic hormone, glucagon thiab insulin, thaum inhibiting qog cell proliferation thiab txo cov angiogenesis. Nws cov qauv cyclic thiab D-amino acid hloov kho tau zoo heev txhim kho peptidase tsis kam thiab hauv vivo ib nrab- lub neej. Nws qhia meej cov tshuaj hormones-inhibiting thiab tiv thaiv- cov qog nqaij hlav loj hlob hauv cov qauv ntawm Cushing's kab mob, acromegaly thiab neuroendocrine hlav. Nws yog cov cuab yeej tseem ceeb peptide rau kev tshawb nrhiav kab mob endocrine mechanism, neuroendocrine oncology thiab peptide tshuaj txhim kho. Cushing's kab mob kev tshawb fawb, kev tshawb fawb acromegaly, kev tshawb fawb neuroendocrine qog, kev tshawb fawb endocrine hormone tswj, kev txhim kho tshuaj peptide Somatostatin receptor 1/2/3/5 (SSTR1/2/3/5); Hormone secretion suppression thiab tiv thaiv -tumor proliferation pathway

 

 

 

 

 

 

 

 

 

Cim npe nrov: cas:396091-77-3: pasireotide l-aspartate ntsev, Tuam Tshoj cas:396091-77-3: pasireotide l-aspartate ntsev manufacturers, lwm tus neeg, Hoobkas

Xa kev nug